TY  - JOUR
AU  - Garcia-Torres, Francisco
AU  - Tejero-Perea, Adrián
AU  - Gomez-Solis, Angel
AU  - Castillo-Mayen, Rosario
AU  - Jaen-Moreno, Maria Jose
AU  - Luque, Barbara
AU  - Galvez-Lara, Mario
AU  - Sanchez-Raya, Araceli
AU  - Jablonski, Marcin
AU  - Rodriguez-Alonso, Beatriz
AU  - Aranda, Enrique
PY  - 2022
DO  - 10.1186/s13063-022-06731-w
UR  - http://hdl.handle.net/10668/20356
T2  - Trials
AB  - Cancer survivors frequently develop cognitive impairment, which negatively affects their quality of life and emotional well-being. This study compares the effectiveness of a well-established treatment (neuropsychological treatment) with the Unified...
LA  - en
PB  - BioMed Central
KW  - Anxiety and depression
KW  - Cancer
KW  - Cognitive impairment
KW  - Oncology
KW  - Quality of life
KW  - Unified protocol for transdiagnostic treatment of emotional disorders (UP)
KW  - Anxiety
KW  - Anxiety disorders
KW  - Cancer survivors
KW  - Cognitive dysfunction
KW  - Humans
KW  - Neoplasms
KW  - Quality of life
KW  - Randomized controlled trials as topic
KW  - Treatment outcome
TI  - Effectiveness of the Unified Barlow Protocol (UP) and neuropsychological treatment in cancer survivors for cognitive impairments: study protocol for a randomized controlled trial.
TY  - research article
VL  - 23
ER  -